Credit Suisse Ag Ab Cellera Biologics Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 4,547,315 shares of ABCL stock, worth $12.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,547,315

Previous 4,578,250 0.68%

Holding current value

$12.4 Million

Previous $26.1 Million 21.2%

% of portfolio

0.02%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$4.29 - $5.97 $132,711 - $184,681	-30,935 Reduced 0.68%	4,547,315 $20.6 Million
Q4 2023 Feb 08, 2024	BUY	$3.91 - $5.93 $20,617 - $31,268	5,273 Added 0.12%	4,578,250 $26.1 Million
Q3 2023 Nov 13, 2023	SELL	$4.6 - $7.95 $7,401 - $12,791	-1,609 Reduced 0.04%	4,572,977 $21 Million
Q2 2023 Aug 11, 2023	SELL	$5.66 - $7.59 $190,028 - $254,826	-33,574 Reduced 0.73%	4,574,586 $29.6 Million
Q1 2023 May 10, 2023	BUY	$7.31 - $11.18 $3.71 Million - $5.68 Million	507,665 Added 12.38%	4,608,160 $34.7 Million
Q4 2022 Feb 13, 2023	SELL	$9.48 - $14.52 $9,252 - $14,171	-976 Reduced 0.02%	4,100,495 $41.5 Million
Q3 2022 Nov 10, 2022	BUY	$9.2 - $13.68 $13.9 Million - $20.6 Million	1,507,513 Added 58.12%	4,101,471 $40.6 Million
Q2 2022 Aug 12, 2022	SELL	$5.72 - $10.65 $347,524 - $647,051	-60,756 Reduced 2.29%	2,593,958 $27.6 Million
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $241,621 - $457,980	32,389 Added 1.24%	2,654,714 $25.9 Million
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $2.34 Million - $3.19 Million	-180,086 Reduced 6.43%	2,622,325 $37.5 Million
Q3 2021 Nov 12, 2021	BUY	$14.85 - $21.34 $2.47 Million - $3.56 Million	166,638 Added 6.32%	2,802,411 $56.2 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $7.37 Million - $12.5 Million	364,973 Added 16.07%	2,635,773 $58 Million
Q1 2021 May 14, 2021	BUY	$23.29 - $53.2 $52.9 Million - $121 Million	2,270,800 New	2,270,800 $77.1 Million

Others Institutions Holding ABCL

# of Institutions

171

Shares Held

119M

Call Options Held

239K

Put Options Held

200K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $778M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account